Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.

Clinical cancer research : an official journal of the American Association for Cancer Research(2023)

引用 1|浏览17
暂无评分
摘要
We provide prospective, preliminary evidence that MET and FGFR are biologically active and safely targetable pathways in AML.
更多
查看译文
关键词
refractory acute myeloid leukemia,acute myeloid leukemia,fgfr,met
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要